Testagen Research, Specifications & Scientific Information

Introduction

Testagen is a four-residue peptide, Lys-Glu-Asp-Gly, and the most useful thing to know about it is that its name and its literature point in different directions.

The name assigns it to the male reproductive system, and the originating group's own 2021 review lists it that way ^[7]. The primary papers that actually use the sequence say something else: they describe it as synthesised from the amino acid composition of anterior pituitary cytomedins, and they study it in the thyroid gland and the thymus of hypophysectomised chickens and hens ^{[4, 3, 2]}. No study of this tetrapeptide in reproductive tissue has been located in the indexed literature. That is not a claim that the name is wrong; it is a statement about where the published evidence is, which is somewhere else.

The shared limitations of this family apply here and are set out once. Nearly all biological work originates with the St Petersburg Institute of Bioregulation and Gerontology and collaborating Russian institutions; group sizes are unstated in the indexed abstracts; the animal model is avian; no clinical report of any design exists; and there is no independent replication of the biological findings. The one recent paper from an unconnected group is not biological at all — it characterises the peptide as a corrosion inhibitor on copper ^[6].

What Is Testagen?

A synthetic tetrapeptide with free termini, KEDG in single-letter code: L-lysyl-L-alpha-glutamyl-L-alpha-aspartyl-glycine.

Structurally it is Epitalon with one substitution. Epitalon is Ala-Glu-Asp-Gly; this peptide replaces the N-terminal alanine with lysine, exchanging a methyl group for a four-carbon chain ending in a basic amine. Everything else is identical.

That relationship is not incidental to the literature — it is the design of it. All three avian studies test the two peptides together, describing this one as the peptide of the anterior pituitary lobe and Epitalon as the peptide of the posterior lobe ^{[4, 3, 2]}. A single-substitution pair tested head to head in the same animals is the most informative structure–activity design available anywhere in this batch, and it is worth more than the many experiments in which four unrelated peptides are reported to do the same thing.

Testagen has not been approved by the U.S. Food and Drug Administration for any indication. No marketing application is on record in the United States, and no study of it appears on ClinicalTrials.gov.

Testagen Specifications

PubChem carries the free tetrapeptide as compound identifier 123863700, formula C17H29N5O9 and an average mass of 447.44 g/mol. No CAS registry number and no FDA/NCATS unique ingredient identifier resolve for it, so both fields are published as unknown rather than estimated — this is one of the more thinly registered compounds in the series. The sequence is stated as Lys-Glu-Asp-Gly in every primary paper located, and the identification of that sequence with the trade name Testagen appears both in a 2011 nuclear-penetration study and in the originating group's 2021 systematic review. Note the relationship to Epitalon, Ala-Glu-Asp-Gly: the two differ only in the first residue, lysine against alanine, and they are tested together in most of the animal work on this compound.

Values that a public register does not carry are shown as not publicly characterised rather than estimated. Identifiers are reference values; the certificate of analysis supplied with a laboratory order is the record for a given lot.

How Does Testagen Work?

Not established. No receptor has been identified, none is proposed, and the specification table therefore shows primary target, receptor family and agonist status as not publicly characterised.

The nucleic-acid hypothesis, and what supports it. Fluorescein-labelled peptide was incubated with HeLa cells and marked fluorescence appeared in the cytoplasm, the nucleus and the nucleolus — the observation on which the whole series' intracellular claim rests. Binding was then measured indirectly, through the quenching of fluorescence in labelled deoxyribooligonucleotides and in DNA–ethidium bromide complexes, with Stern-Volmer constants differing according to the peptide's primary structure and the oligonucleotide's sequence. The binding discriminated even the cytosine methylation status of otherwise identical sequences. This peptide, with Epitalon and Pinealon, bound preferentially to CAG-containing sequences, where Bronchogen preferred CTG ^[1].

What that does and does not show. Fluorescence of a labelled peptide inside a cell shows that the conjugate got in; it does not show that the unlabelled peptide does, and a fluorescein label is a large addition to a 447-dalton molecule. A quenching constant measured in a cuvette is a real binding measurement on purified components. Neither shows that binding occurs at a relevant site in a living nucleus, or that it changes transcription.

Histones too. A later paper reported that this peptide and five siblings bind FITC-labelled wheat histones H1, H2B, H3 and H4, with binding depending on the histone, on the peptide's primary structure and on the oligonucleotides present, and suggested interaction with the N-terminal histone regions ^[5].

What is entirely absent. No pharmacokinetic dataset in any species. No mammalian in vivo study of this compound. No connection published between the binding data and the endocrine results in birds.

Preclinical Research on Testagen

Animal research

All in vivo work located for this tetrapeptide is avian, and all of it uses hypophysectomy — surgical removal of the pituitary — to create the deficit being tested. The model is chosen because it is practical in birds and produces a clean endocrine lesion; the cost is that avian endocrinology differs substantially from mammalian, which limits how far any of it extends.

Thyroid structure and function in neonatally hypophysectomised chickens

Chickens hypophysectomised as neonates received this tetrapeptide or Epitalon for 40 days. Concentrations of thyrotropic hormone and of thyroid hormones increased and thyroid gland structure was reported to recover ^[4].

The same endpoints in chickens and in old hens

A later report extended the comparison by age. Hypophysectomy in 5-day-old chickens and in old hens was followed by hormonal disturbance and structural change in the thyroid. Forty days of either peptide significantly reduced the degree of those changes — and the normalising effect on thyrotropic and thyroid hormone concentrations was less pronounced in the old hens than in the chickens ^[3].

That age result runs against the direction claimed for most of this series, where effects are usually reported as larger in aged systems. An inconsistency of that kind inside one research programme is worth recording.

Thymus morphology in hypophysectomised young and old birds

The most pronounced changes in thymus morphology followed neonatal hypophysectomy, and were least pronounced in old chicks. Both peptides, given to hypophysectomised birds regardless of age, promoted recovery of thymic morphological structure — and the anterior pituitary peptide, this one, had a more pronounced effect than Epitalon ^[2].

This is the clearest separation of the two sequences in the whole record, and it is the one point at which the single-residue difference between them is reported to matter directionally.

Limitations across all three. No indexed abstract states group sizes, route, amount administered, randomisation, blinding or statistical tests. Histological assessment of thyroid and thymus structure is subjective and, so far as the record shows, unblinded. All three come from the same author group.

Findings in this section were obtained in chickens and hens. Nothing in them establishes anything about mammals, and nothing about humans.

Testagen Mechanism of Action

In vitro research

Nuclear penetration and sequence-selective binding. Described above: fluorescein-labelled peptide distributed to cytoplasm, nucleus and nucleolus in HeLa cells; Stern-Volmer quenching constants varied with peptide and with oligonucleotide sequence and methylation state; this peptide preferred CAG-containing sequences ^[1].

Histone binding. Reported for this peptide among six, against wheat histones H1, H2B, H3 and H4 and their complexes with deoxyribooligonucleotides, with histone H1 binding single-stranded oligonucleotides preferentially and core histones binding methylated double-stranded ones ^[5].

Adsorption on copper. In 2025 an electrochemistry group at a Romanian university studied the tetrapeptide as a corrosion inhibitor for copper in sodium chloride solution. Inhibition efficiency reached about 86%; the data fitted a Freundlich adsorption isotherm; the standard free energy of adsorption was −30.86 kJ/mol, indicating a mixture of physical and chemical adsorption; scanning electron microscopy with energy-dispersive spectroscopy found a surface layer containing the peptide, sodium chloride and copper corrosion products; and density functional theory with Monte Carlo simulation reproduced the experimental result ^[6].

This paper is not about biology and makes no biological claim. It is included here for two reasons. It is the only recent study of this specific compound by a group with no connection to the originating programme — which, for a compound whose biological literature is entirely in-house, is worth marking. And the property it measures is real and characterised: a molecule with a lysine amine, two carboxylates and a glycine terminus adsorbs strongly to a metal surface. That is a statement about the peptide's affinity for charged surfaces generally, which is worth holding in mind when reading claims about its affinity for DNA.

Findings in this section were obtained in cultured cells, on purified nucleic acids and proteins, and on metal surfaces.

What Is Testagen Being Researched For?

• Avian endocrine restoration after hypophysectomy — thyroid structure and hormone concentrations, and thymus morphology ^{[4, 3, 2]}.
• Peptide–DNA interaction — nuclear distribution and sequence-selective binding including methylation discrimination ^[1].
• Peptide–histone interaction — binding to four histone classes and their nucleic acid complexes ^[5].
• Metal surface adsorption — copper corrosion inhibition, experimental and computational ^[6].

None of that is research into, or evidence about, research-grade material supplied for laboratory use. No research into the tissue the compound is named for has been located.

Current Research Status

Status as of September 22, 2026. This block is rendered from maintained fields, not from prose, so it cannot go stale in one place and stay current in another.

Testagen vs Related Compounds

Epitalon :: Ala-Glu-Asp-Gly — this sequence with alanine in place of the N-terminal lysine. The pair is tested head to head in all three avian studies and separated in one of them, where this peptide had the larger effect on thymic structure ^[2]. It is the single most informative comparison in this batch, precisely because only one residue differs. Pinealon and Bronchogen :: The other two peptides in the DNA-binding study. All bound CNG-containing sequences; this one and Pinealon and Epitalon preferred CAG, Bronchogen preferred CTG ^[1]. Vesugen, Livagen, Pancragen and Prostamax :: The other members of the Lys-Glu-Asp family, differing from this one only in the fourth position. Glycine — the residue this peptide carries there — is the only achiral standard amino acid and contributes no side chain at all, which makes this the most minimal of the five.

Name against evidence

The compound is listed by its originators as a regulator of male reproductive function ^[7] and studied in thyroid, thymus and DNA. This page reports the gap rather than resolving it.

Evidentiary position

Not approved by the U.S. Food and Drug Administration, no registered trial, no clinical report of any design, and no mammalian in vivo study located.

No comparison of effect between these compounds is made on this page.

Chemical & Molecular Characteristics

Glycine at the C-terminus makes this the least structured member of its family. Glycine has no side chain — a hydrogen atom in place of one — and is the only achiral standard amino acid. It contributes no steric constraint, so the backbone around it samples a wider range of conformations than any other residue would allow. Whatever governs this peptide's binding preferences, it is not shape imposed by the fourth residue.

Charge is balanced but polarity is extreme. The lysine side-chain amine and the N-terminal amine sit against the glutamate side chain, the aspartate side chain and the C-terminal carboxyl. There is no hydrophobic surface anywhere on the molecule. Reversed-phase retention on conventional C18 is correspondingly poor, and a peptide eluting near the void volume is hard to resolve from salts and from synthesis-related impurities — so a bare "purity by HPLC" figure means little without the method behind it.

No aromatic residue, so no absorbance at 280 nm. Quantification relies on peptide-bond absorbance near 214 nm, where buffers and solvents also absorb.

Aspartate and glutamate bring isomers of identical mass. Both residues undergo alpha/beta and alpha/gamma rearrangement under thermal and acidic stress, giving species with the same molecular formula and the same mass as the intended compound. And because this sequence differs from Epitalon only at position one, a synthesis error at that position produces a different, well-known peptide rather than an obvious failure — another reason that mass alone is not identity here.

Two register fields are empty and stay empty. No CAS registry number and no FDA/NCATS unique ingredient identifier resolve for this tetrapeptide; only the PubChem compound identifier 123863700 does. They are shown as unknown above rather than filled with a neighbouring substance's numbers.

Frequently Asked Questions

Scientific References

1. Fedoreyeva LI, Kireev II, Khavinson VKh, et al.. Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA Biochemistry. Biokhimiia; 2011. PMID 22117547 doi:10.1134/S0006297911110022
2. Pateyk AV, Baranchugova LM, Rusaeva NS, et al.. Effect of peptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly on the morphology of the thymus in hypophysectomized young and old birds Bulletin of experimental biology and medicine; 2013. PMID 23658898 doi:10.1007/s10517-013-2029-0
3. Kuznik BI, Pateyuk AV, Rusaeva NS, et al.. Effects of peptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly on hormonal activity and structure of the thyroid gland in hypophysectomized young chickens and old hens Bulletin of experimental biology and medicine; 2011. PMID 22268052 doi:10.1007/s10517-011-1177-3
4. Kuznik BI, Pateyuk AV, Rusaeva NS. Effect of tetrapeptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly on the structure and function of the thyroid gland in neonatally hypophysectomized chickens Bulletin of experimental biology and medicine; 2008. PMID 19024016 doi:10.1007/s10517-008-0033-6
5. Fedoreyeva LI, Smirnova TA, Kolomijtseva GY, et al.. Interaction of short peptides with FITC-labeled wheat histones and their complexes with deoxyribooligonucleotides Biochemistry. Biokhimiia; 2013. PMID 23581987 doi:10.1134/S0006297913020053
6. Dobriţescu A, Samide A, Cioateră N, et al.. The Inhibitory Effect and Adsorption Properties of Testagen Peptide on Copper Surfaces in Saline Environments: An Experimental and Computational Study Molecules (Basel, Switzerland); 2025. PMID 40807317
7. Khavinson VK, Popovich IG, Linkova NS, et al.. Peptide Regulation of Gene Expression: A Systematic Review Molecules (Basel, Switzerland); 2021. PMID 34834147 doi:10.3390/molecules26227053

Every identifier above is resolved against PubMed, Crossref or ClinicalTrials.gov at build time, and the title returned by the register is compared with the title stored here. A page does not publish if a reference fails to resolve.

Research-Use Information

For in vitro research use only. This material is a laboratory reagent. It is not a drug, food, dietary supplement, or cosmetic and is not for human or veterinary use, including ingestion, injection, or any other administration. No information on this page describes or implies any effect in humans or animals. Sold only to researchers under our Terms of Sale.